Project Grant R01DA063537
Award Date 5/15/26
Completion Date 2/28/31
Dollars Obligated $731K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Eugene, OR 97403, USA
Similar Awards
- Federal Project Grant Award Summary The University of Oregon received a $407,812 Project Grant (R21) award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), with an award date of September 10, 2025, and completion date of August 31, 2027. This research initiative examines the dynamic associations between impulsivity, craving, and the co-use of alcohol, cannabis, and nicotine among young adults. The project will collect...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- Federal Project Grant Award Summary The University of Oregon received a $149,000 Project Grant award (effective July 1, 2025, through June 30, 2027) from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal secondary analysis examining the developmental trajectories of parasympathetic nervous system (PNS) functioning in children prenatally exposed to tobacco and/or cannabis. The research deliverables include multi-method,...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Oregon Health & Science University a Project Grant totaling $452,522 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods implementation research study examining electronic nicotine delivery systems (ENDS) assessment and cessation support practices in primary care settings. The award was obligated on May 1, 2026, with a completion date of April 30, 2028. The research will...
- Federal Project Grant Award Summary Oregon Health & Science University received a $429,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 15, 2025, with a completion date of June 30, 2027. The award funds research to develop innovative photopharmacological tools for investigating tetrahydrocannabinol (THC) signaling mechanisms in brain reward circuits. The primary deliverable is the advancement...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $2.29 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 1, 2025, with completion targeted for March 31, 2030. The grant supports a comprehensive research initiative examining opioid use disorder (OUD) treatment delivery via telehealth within community health centers (CHCs). The study utilizes nearly a decade of...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $1.19M Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a three-year mechanistic research study on the bidirectional relationships between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis. The research addresses the significant public health gap regarding cannabis use disorder (CUD),...
- Federal Grant Award Summary The University of Oregon received a $406,051 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 15, 2025 through May 31, 2027. This research award supports a genetic analysis study investigating psychoplasticity in Caenorhabditis elegans to advance understanding of how psychedelic compounds may treat intractable psychiatric diseases, including depression,...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Vermont & State Agricultural College a $387,291 Project Grant, effective March 1, 2026, through December 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative delivers comprehensive neuroimaging and behavioral analysis services to delineate developmental windows of vulnerability to cannabis exposure and establish causal relationships between...
- Federal Grant Award Summary Biomotivate LLC received a $613,744 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to support individuals with opioid use disorders (OUDs). The award, issued August 1, 2025, with completion targeted for July 31, 2026, funds the creation of a novel digital...